Click on headlines below to download research

Strategic review complete: focus on deal-making
e-Therapeutics | 27/07/2017

New CEO Dr Ray Barlow, who joined e-Therapeutics (ETX) in April, has undertaken a business and strategic review, assisted by an independent industry-wide…

Right place, right time
e-Therapeutics | 05/05/2017

e-Therapeutics offers public market investors a unique opportunity to gain exposure to a proprietary, cutting-edge in silico drug discovery platform that…

Embarking on the next phase: Deals and data
e-Therapeutics | 16/01/2017

e-Therapeutics (ETX) has appointed a new CEO, Dr Raymond Barlow, who will join the company by 1 May 2017. He brings significant R&D and business development…